Filter anzeigen
Art der Ressourcen
Filtern nach Art der Ressourcen
Pathologien
Filtern nach Pathologien
Technologien
Filtern nach Technologien
Geräte
Filtern nach Geräte
92 Ergebnis(se) gefunden
Sortieren nach:

HEp-2 cells: a reliable tool for antinuclear antibodies screening

Whitepaper
Jan. 02, 2025

A comprehensive overview of Sebia’s solutions for ANA screening for Connective tissue disease diagnosis.

Customer Testimonial about the Alegria 2

Neuigkeiten
Jan. 02, 2025

The Alegria 2 provides the possibility of giving results to clinicians within a timeframe fitting clinical needs and helps to optimize the patient’s care pathway.

Alegria 2 properties and workflow

Video
Jan. 02, 2025

Obtain your patients results with high flexibility reliability and efficiency with Alegria 2.

Automated analysis of a comprehensive profile of stool and serological biomarkers with Alegria

Broschüre
Jan. 02, 2025

A fully dedicated test portfolio to the diagnosis of inflammatory bowel diseases.

Automated analysis of stool biomarkers with Alegria

Veröffentlichung
Jan. 02, 2025

Alegria fecal calprotectin reduces TAT helping in the diagnosis of inflammatory bowel diseases with robust results.

The importance of testing anti-dsDNA, anti-nucleosome and anti-C1q antibodies in patients with systemic lupus erythematosus

Veröffentlichung
Jan. 02, 2025

The flexibility of Alegria monotest solution helps the correct stratification of the SLE patient population.

A quick and pocketable guide helping in the daily routine with HEp-2 cells

Broschüre
Jan. 02, 2025

Sebia’s HEp-2 cells quality at a glance in a complete atlas of images.

Anti-MCV – Fill the gap in rheumatoid arthritis diagnosis

Veröffentlichung
Jan. 02, 2025

This comprehensive meta-analysis highlights the benefit of testing anti-MCV additionally to anti-CCP and RF in the context of early diagnosis of Rheumatoid Arthritis.